Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients
Clinical trial NCT01911325 · TERMINATED
Trial details
- NCT number
- NCT01911325
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-08-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.